Hypocalcaemic cardiomyopathy: a description of two cases and a literature review

AbstractHypocalcaemic cardiomyopathy is a rare form of dilated cardiomyopathy. The authors here present two cases in which symptomatic dilated cardiomyopathy was the result of severe hypocalcaemia. First, we report about a 26 ‐year‐old woman with primary hypoparathyroidism and then about a 74‐year‐old man with secondary hypoparathyroidism following a thyroidectomy. In both cases, the left ventricular systolic function improved after calcium supplementation. In the first case, a lack of compliance led to a repeate d decrease of both serum calcium level and left ventricular systolic function. The authors also present a comprehensive summary of all cases of hypocalcaemic dilated cardiomyopathy that have been described in literature to date. The mean age of the affected patients was 48.3 years, of which 62% wer e female patients. The most common causes of hypocalcaemic cardiomyopathy are primary hypoparathyroidism (50%) and post‐thyroidectomy hypoparathyroidism (26%). In the post‐thyroidectomy subgroup, the median time for the development of hypocalcaemic cardiomyopathy is 10 years (range: 1.5 months to 36 years). Hypocalcaemic cardiomyopathy leads to heart failure with reduced ejection fraction in 87% of patients. Generally, the most common complications of hypoparathyroidism and/or hypocalcaemia are cerebral calcifications, cognitive deficit, and cataracts. Once calcium supplementation is ad ministered, the disease has a good prognosis and, in mo...
Source: ESC Heart Failure - Category: Cardiology Authors: Tags: Review Source Type: research

Related Links:

His group will study how abnormal calcium signals may contribute to human diseases such as allergies and asthma. (read more)
Source: Environmental Factor - NIEHS Newsletter - Category: Environmental Health Source Type: news
Sometimes when the discussion of tackling the novel coronavirus comes up, the use of medical devices gets lost in the shuffle. Most of the conversation surrounding COVID-19 comes from either the promise of a vaccine or the expansion of tests. Abiomed is adding to the conversation surrounding medtech’s potential contribution to the treatment of COVID-19 patients. Monday, the Danvers, MA-based company by receiving Emergency Use Authorization for a device to treat COVID-19 related right heart failure patients. The Impella RP is a temporary heart pump that provides circulatory support for patients who develop...
Source: MDDI - Category: Medical Devices Authors: Tags: Cardiovascular COVID-19 Source Type: news
CONCLUSION: We report the successful management of anesthesia without lethal arrhythmia in a patient with ARVC and an ICD. An adequate amount of analgesia should be administered during general anesthesia to maintain adequate anesthetic depth and to avoid stress and pain. PMID: 32473832 [PubMed - as supplied by publisher]
Source: Revista Brasileira de Anestesiologia - Category: Anesthesiology Tags: Rev Bras Anestesiol Source Type: research
Resumo A doen ça de coronavírus 2019 (COVID-19) é uma pandemia global afetando o mundo, estando presente em mais de 1.300.000 pacientes. O COVID-19 age pelo receptor da enzima conversora de angiotensina 2 (ECA2). As comorbidades cardiovasculares são mais frequentes com COVID-19, e cerca 10% de casos desenvolv em miocardite (22% de pacientes críticas). Mais pesquisas serão necessárias para continuar ou descontinuar inibidores de ECA e bloqueadores dos receptores da angiotensina, que são essenciais para hipertensão e insuficiência cardíaca em COVID-1...
Source: Arquivos Brasileiros de Cardiologia - Category: Cardiology Source Type: research
Resumo Os sintomas respirat órios, principalmente o desenvolvimento de quadros de síndrome do desconforto respiratório agudo grave, dominam a discussão e as preocupações iniciais da população e dos profissionais de saúde. Entretanto, o sistema cardiovascular é bastante afetado por essas condições e, muitas vezes, é o responsável por complicações e mortalidade desses pacientes. Com o objetivo de mostrar as implicações cardiovasculares em pacientes infectados pela COVID-19 e a importância do iso...
Source: Arquivos Brasileiros de Cardiologia - Category: Cardiology Source Type: research
The authorization allows use of the temporary heart pump in the treatment of right heart failure or decompensation, including pulmonary embolism, caused by COVID-19 complications.FDA Approvals
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Alert Source Type: news
Publication date: Available online 31 May 2020Source: Colloids and Surfaces A: Physicochemical and Engineering AspectsAuthor(s): Zilong Liu, Pegah Hedayati, Ernst J.R. Sudhölter, Robert Haaring, Abdur Rahman Shaik, Naveen Kumar
Source: Colloids and Surfaces A: Physicochemical and Engineering Aspects - Category: Chemistry Source Type: research
Analyst, 2020, Accepted Manuscript DOI: 10.1039/D0AN00454E, CommunicationYu Li, Junjun Feng, Yuchen Huang, Yu Qin, Dechen Jiang, Hong-Yuan Chen Upconverting ion-selective nanoparticles are prepared here that emit the light at near-infrared region. The transport of calcium ions induces the deprotonation of the incorporated chromoionophore (P6) through ion exchange resulting... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Analyst latest articles - Category: Chemistry Authors: Source Type: research
Guest: Eric D. Donnenfeld, M.D. Clinical Professor of Ophthalmology New York University In practice at OCLI Vision Garden City, NY
Source: As Seen From Here - Category: Opthalmology Authors: Source Type: podcasts
Publication date: Available online 31 May 2020Source: Revista Clínica Española (English Edition)Author(s): A. González-Franco, L. Manzano
Source: Revista Clinica Espanola - Category: Internal Medicine Source Type: research
More News: Calcium | Cardiology | Cardiomyopathy | Cataracts | Dilated Cardiomyopathy | Heart | Heart Failure | Hypocalcaemia | Thyroidectomy